News about Global Pharma

Moderna Secures US FDA Approval for COVID-19 Vaccine mNEXSPIKE

Moderna has received FDA approval for mNEXSPIKE (mRNA-1283), its next-generation COVID-19 vaccine, for adults 65+ and at-risk individuals aged 12–64, ahead of the 2025–2026 respiratory virus season.

Global Pharma | 02/06/2025 | By Manvi |  268

Astellas Signs Exclusive Licensing Agreement with Evopoint Biosciences for Novel CLDN18.2-Targeting ADC XNW27011

Astellas Pharma has entered an exclusive licensing agreement with Evopoint Biosciences for XNW27011, a clinical-stage antibody-drug conjugate targeting CLDN18.2 for the treatment of solid tumours.

Global Pharma | 31/05/2025 | By Manvi |  224

Eton Pharmaceuticals Secures US FDA Approval for KHINDIVI Oral Solution

Eton Pharmaceuticals has received FDA approval for KHINDIVI, the first and only oral hydrocortisone solution for paediatric patients aged 5 and older with adrenocortical insufficiency, offering precise, ready-to-use dosing without the need for tablet splitting.

Global Pharma | 31/05/2025 | By Manvi |  439

Terumo Launches ROADSAVER Carotid Stent System for Commercial Use

Terumo Interventional Systems (TIS), a division of Terumo Corporation, announces the early commercial availability of its FDA-approved ROADSAVER™ Carotid Stent System. Indicated for use with the Nanoparasol® Embolic Protection System, ROADSAVER Stent System addresses carotid artery stenosis in patients with increased risk of adverse events

Global Pharma | 28/05/2025 | By Manvi |  422

Olympus Receives FDA Clearance for EZ1500 Endoscopes with EDOF Technology

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced FDA 510(k) clearance of its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF™) technology.

Global Pharma | 28/05/2025 | By Manvi |  444

Sandoz Introduces Pyzchiva Autoinjector, First Commercially Available in Europe for Ustekinumab Biosimilars

Sandoz has launched Pyzchiva, the first ustekinumab biosimilar autoinjector in Europe, aiming to enhance patient comfort and adherence in the treatment of chronic inflammatory diseases.

Global Pharma | 27/05/2025 | By Manvi |  297

Unicon Pharma Partners with VRR Life Sciences to Expand Global CSV Capabilities

Unicon Pharma has partnered with Bengaluru-based VRR Life Sciences to expand global computer system validation (CSV) services and drive digital transformation in the life sciences industry.

Global Pharma | 27/05/2025 | By Manvi |  505

Zylox-Tonbridge Secures First International Approval for Vascular Device in Indonesia

Zylox-Tonbridge Medical Technology Co., Ltd. announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn™ Vascular Closure Device's first international market clearance and the Company's first market authorization in Southeast Asia.

Global Pharma | 27/05/2025 | By Manvi |  256

Delta Development's Blood Coolers Set New Standard for Prehospital Care Across US

Delta Development Team (DDT) announce that its innovative APRU 6L portable blood refrigerator and Delta ICE 2L Smart Blood Cooler are setting a national benchmark for prehospital blood storage and transport, revolutionizing healthcare on both the West and East coasts, helping emergency services deliver life-saving care from California to New Jersey.

Global Pharma | 27/05/2025 | By Manvi |  190

Mindray Launches BeneVision V Series at Euroanaesthesia 2025 in Lisbon

Mindray launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon.

Global Pharma | 26/05/2025 | By Manvi |  416